{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T07:10:34Z","timestamp":1777965034983,"version":"3.51.4"},"reference-count":39,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"unspecified","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023833","name":"World Scleroderma Foundation","doi-asserted-by":"crossref","award":["UH&UHR1"],"award-info":[{"award-number":["UH&UHR1"]}],"id":[{"id":"10.13039\/501100023833","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100018950","name":"CHU Rennes","doi-asserted-by":"crossref","award":["AO CORECT 2020"],"award-info":[{"award-number":["AO CORECT 2020"]}],"id":[{"id":"10.13039\/501100018950","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008604","name":"Scleroderma and Raynaud\"s UK","doi-asserted-by":"publisher","award":["UH&UHR1"],"award-info":[{"award-number":["UH&UHR1"]}],"id":[{"id":"10.13039\/501100008604","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K24 AR063120"],"award-info":[{"award-number":["K24 AR063120"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["T32 AR007080"],"award-info":[{"award-number":["T32 AR007080"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"name":"French network of the University Hospitals HUGO","award":["AAP JCM2020"],"award-info":[{"award-number":["AAP JCM2020"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,1,28]]},"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Limited cutaneous systemic sclerosis (lcSSc) is the most frequent subset of systemic sclerosis. Despite this, lcSSc is not the major focus of clinical studies. The lack of interventional studies in lcSSc is due, in part, to a paucity of relevant outcome measures to effectively evaluate this subset. A combined response index dedicated to lcSSc would facilitate development of well-designed trials and approval of new drugs. The objective of this scoping review is to perform a broad and comprehensive identification of the outcome measures (core set items) within relevant domains, which have been used so far to assess lcSSc.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>\n                      The planned scoping review will be based on the approach proposed by Arksey\n                      <jats:italic>et al<\/jats:italic>\n                      and further developed by Levac\n                      <jats:italic>et al<\/jats:italic>\n                      . Development and reporting will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses\u2014Extension for Scoping Reviews checklist and guidelines. The development of the search strategy was guided by the concepts of domains and outcomes based on the Outcome Measures in Rheumatology approach and by the different names and definitions of SSc, with a specific emphasis on their occurrence in clinical trial studies. Two databases will be searched: MEDLINE and Embase. Studies in English, published from the year 1988 onwards, will be included, since 1988 corresponds to the publication of LeRoy\u2019s first consensus definition of lcSSc. Data will be extracted and analysed using a standardised charting tool.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>No ethical approval is required for this study. The results will be submitted to an international peer-reviewed journal and scientific conferences, informing the discussion on which items should be included in a combined response index dedicated to lcSSc (the CRISTAL project: Combined Response Index for Scleroderma Trial Assessing lcSSc).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-044765","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T10:56:03Z","timestamp":1615460163000},"page":"e044765","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Domains and outcome measures for the assessment of limited cutaneous systemic sclerosis: a scoping review protocol"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2081-8558","authenticated-orcid":false,"given":"Alain","family":"Lescoat","sequence":"first","affiliation":[{"name":"Internal Medicine & Clinical Immunology, CHU Rennes, Rennes, France"},{"name":"Scleroderma Program, University of Michigan, Ann Arbor, Michigan, USA"},{"name":"Department of Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA"},{"name":"Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de Recherche en Sant\u00e9, Environnement et Travail) - UMR_S 1085, Rennes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Roofeh","sequence":"additional","affiliation":[{"name":"Scleroderma Program, University of Michigan, Ann Arbor, Michigan, USA"},{"name":"Department of Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Whitney","family":"Townsend","sequence":"additional","affiliation":[{"name":"Taubman Health Sciences Library, University of Michigan, Ann Arbor, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Hughes","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D","family":"Sandler","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Zimmermann","sequence":"additional","affiliation":[{"name":"Internal Medicine & Clinical Immunology, CHU Rennes, Rennes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D","family":"Pauling","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Royal National Hospital For Rheumatic Diseases (at Royal United Hospitals), University of Bath, Bath, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8962-5642","authenticated-orcid":false,"given":"Maya H","family":"Buch","sequence":"additional","affiliation":[{"name":"Centre for Musculoskeletal Research, School of Biological Sciences, Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK"},{"name":"NIHR Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, Manchester University Foundation Trust, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1412-4453","authenticated-orcid":false,"given":"Dinesh","family":"Khanna","sequence":"additional","affiliation":[{"name":"Scleroderma Program, University of Michigan, Ann Arbor, Michigan, USA"},{"name":"Department of Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,3,11]]},"reference":[{"key":"2025120618015026000_11.3.e044765.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30933-9"},{"key":"2025120618015026000_11.3.e044765.2","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1093\/rheumatology\/key214","article-title":"Synovial involvement assessed by power Doppler ultra-sonography in systemic sclerosis: results of a cross-sectional study","volume":"57","author":"Lescoat","year":"2018","journal-title":"Rheumatology"},{"key":"2025120618015026000_11.3.e044765.3","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"2025120618015026000_11.3.e044765.4","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol"},{"key":"2025120618015026000_11.3.e044765.5","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102452","article-title":"Outcomes of limited cutaneous systemic sclerosis patients: results on more than 12,000 patients from the EUSTAR database","volume":"19","author":"Frantz","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2025120618015026000_11.3.e044765.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055120"},{"key":"2025120618015026000_11.3.e044765.7","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2025120618015026000_11.3.e044765.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903076"},{"key":"2025120618015026000_11.3.e044765.9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semarthrit.2016.02.005","article-title":"Impaired quality of life in systemic sclerosis and patient perception of the disease: a large international survey","volume":"46","author":"Frantz","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"2025120618015026000_11.3.e044765.10","doi-asserted-by":"publisher","DOI":"10.1002\/art.22465"},{"key":"2025120618015026000_11.3.e044765.11","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.078923"},{"key":"2025120618015026000_11.3.e044765.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.11.013"},{"key":"2025120618015026000_11.3.e044765.13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/art.39501","article-title":"The American College of Rheumatology provisional composite response index for clinical trials in early diffuse cutaneous systemic sclerosis","volume":"68","author":"Khanna","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2025120618015026000_11.3.e044765.14","doi-asserted-by":"crossref","unstructured":"Khanna D , Huang S , CJF L . New composite endpoint in early diffuse cutaneous systemic sclerosis: revisiting the provisional American College of rheumatology composite response index in systemic sclerosis. Ann Rheum Dis.doi:10.1136\/annrheumdis-2020-219100","DOI":"10.1136\/annrheumdis-2020-219100"},{"key":"2025120618015026000_11.3.e044765.15","doi-asserted-by":"crossref","unstructured":"Lescoat A , Murphy SL , Roofeh D . Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes. J Scleroderma Relat Disord 2020;15.doi:10.1177\/2397198320961967","DOI":"10.1177\/2397198320961967"},{"key":"2025120618015026000_11.3.e044765.16","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.131314"},{"key":"2025120618015026000_11.3.e044765.17","doi-asserted-by":"publisher","DOI":"10.1080\/1364557032000119616"},{"key":"2025120618015026000_11.3.e044765.18","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-5-69"},{"key":"2025120618015026000_11.3.e044765.19","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-018-0611-x"},{"key":"2025120618015026000_11.3.e044765.20","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.181096"},{"key":"2025120618015026000_11.3.e044765.21","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20581"},{"key":"2025120618015026000_11.3.e044765.22","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/S2665-9913(19)30038-4","article-title":"The nosology of systemic sclerosis: how lessons from the past offer new challenges in reframing an idiopathic rheumatological disorder","volume":"1","author":"Lescoat","year":"2019","journal-title":"Lancet Rheumatol"},{"key":"2025120618015026000_11.3.e044765.23","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-120-3-199402010-00004"},{"key":"2025120618015026000_11.3.e044765.24","first-page":"1281","article-title":"Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis","volume":"22","author":"Clements","year":"1995","journal-title":"J Rheumatol"},{"key":"2025120618015026000_11.3.e044765.25","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780401110"},{"key":"2025120618015026000_11.3.e044765.26","doi-asserted-by":"publisher","DOI":"10.1002\/art.20676"},{"key":"2025120618015026000_11.3.e044765.27","doi-asserted-by":"publisher","DOI":"10.1002\/art.22965"},{"key":"2025120618015026000_11.3.e044765.28","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.069518"},{"key":"2025120618015026000_11.3.e044765.29","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.072686"},{"key":"2025120618015026000_11.3.e044765.30","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-207001"},{"key":"2025120618015026000_11.3.e044765.31","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1002\/art.39718","article-title":"Nailfold videocapillaroscopic features and other clinical risk factors for digital ulcers in systemic sclerosis: a multicenter, prospective cohort study","volume":"68","author":"Cutolo","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2025120618015026000_11.3.e044765.32","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1002\/art.40242","article-title":"Efficacy and safety of selexipag in adults with raynaud\u2019s phenomenon secondary to systemic sclerosis: a randomized, placebo-controlled, phase II study","volume":"69","author":"Denton","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2025120618015026000_11.3.e044765.33","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-014-0579-0"},{"key":"2025120618015026000_11.3.e044765.34","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.136929"},{"key":"2025120618015026000_11.3.e044765.35","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850"},{"key":"2025120618015026000_11.3.e044765.36","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7647"},{"key":"2025120618015026000_11.3.e044765.37","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(95)00134-4"},{"key":"2025120618015026000_11.3.e044765.38","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898"},{"key":"2025120618015026000_11.3.e044765.39","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9491-z"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-044765","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T02:02:01Z","timestamp":1765072921000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-044765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,11]]},"published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1136\/bmjopen-2020-044765"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-044765","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}